Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Finatext Holdings, First Half Ordinary Profit Decreases by 13%, Jul-Sep Ordinary Profit Decreases by 43%
4419 Finatext Holdings Ltd. 【J-GAAP】
Earnings ReportFinatext Holdings Ltd. <4419> [TSE Growth] announced its financial results after the market closed on November 12th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2026 (April to September) decreased 13.4% from the same period last year to 0.34 billion yen. Progress toward the full-year plan of 1.84 billion yen was 18.9%, also falling below the same period of the previous year of 42.6%.
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to surge 2.8 times that of the same period last year, reaching 1.49 billion yen.
In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit dropped to 0.13 billion yen, a 42.7% decrease compared to the same period last year. The operating profit margin sharply declined from 13.0% in the same period last year to 5.9%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2023 | 2,086 | -184 | -181 | -311 | -6.3 | ー | Nov 14, 2023 | J-GAAP |
| Apr - Sep, 2024 | 3,451 | 407 | 402 | 287 | 5.7 | 42.6 | Nov 14, 2024 | J-GAAP |
| Apr - Sep, 2025 | 4,464 | 363 | 348 | 495 | 9.7 | 18.9 | Nov 12, 2025 | J-GAAP |
| YoY | +29.4% | -10.8% | -13.4% | +72.5% | +68.9% |
First Half Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2025 Guidance | ー | ー | ー | ー | - | 0 | May 13, 2025 | J-GAAP |
| Apr - Sep, 2025 Results | 4,464 | 363 | 348 | 495 | 9.7 | 0 | Nov 12, 2025 | J-GAAP |
| Revision Rate | - | - | - | - | - |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 4,251 | 543 | 541 | 372 | 7.3 | 0 | May 13, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 6,536 | 1,507 | 1,492 | 715 | 13.9 | 0 | Nov 12, 2025 | J-GAAP |
| YoY | +53.8% | +177.5% | +175.8% | +92.2% | +89.9% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 5,375 | 204 | 194 | -78 | -1.6 | 0 | May 14, 2024 | J-GAAP |
| Mar, 2025 | 7,702 | 950 | 943 | 659 | 13.0 | 0 | May 13, 2025 | J-GAAP |
| Mar, 2026 Guidance | 11,000 | 1,870 | 1,840 | 1,210 | 23.6 | 0 | May 13, 2025 | J-GAAP |
| YoY | +42.8% | +96.8% | +95.1% | +83.6% | +81.5% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Sep, 2024 | 1,807 | 235 | 234 | 170 | 3.4 | 13.0 | Nov 14, 2024 | J-GAAP |
| Oct - Dec, 2024 | 1,741 | 94 | 88 | 126 | 2.5 | 5.4 | Feb 14, 2025 | J-GAAP |
| Jan - Mar, 2025 | 2,510 | 449 | 453 | 246 | 4.9 | 17.9 | May 13, 2025 | J-GAAP |
| Apr - Jun, 2025 | 2,104 | 223 | 214 | 366 | 7.2 | 10.6 | Aug 12, 2025 | J-GAAP |
| Jul - Sep, 2025 | 2,360 | 140 | 134 | 129 | 2.5 | 5.9 | Nov 12, 2025 | J-GAAP |
| YoY | +30.6% | -40.4% | -42.7% | -24.1% | -25.7% |
Related Articles
C.I. MEDICAL, Jul-Sep (3Q) Ordinary Profit Increases by 3.9 times
IBJ, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 12%, Raises Record High Profit Forecast, Dividend Revised Upward by 2 Yen
Photosynth, Jan-Sep (Cumulative 3Q) Ordinary Profit Increases by 90%, Exceeds Full-Year Plan
KIMURATAN, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 56%
CROOZ, The Current Fiscal Year's Undisclosed Ordinary Loss to Narrow
Fuller, Jul-Sep (1Q) Ordinary Profit loss of 4 Million Yen
NIKKO, First Half Ordinary Profit Decreases by 38%
CyberBuzz, 17% Decrease in Ordinary Profit for The Current Fiscal Year
Satoh&Co, First Half Ordinary Profit Unexpectedly Revised Upward by 0.3%
PULSTEC INDUSTRIAL, Jul-Sep (2Q) Ordinary Profit Increases by 2.6 times